| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 216403 | NDA | TRAVERE | 001 | FILSPARI | TABLET;ORAL | 200MG | SPARSENTAN | 2023-02-17 | Prescription | No | |
| 002 | FILSPARI | TABLET;ORAL | 400MG | SPARSENTAN | 2023-02-17 | Prescription | Yes |